Carmelo A. Castello-Juarez

Logrono, LO, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Quality of Life Changes in Respiratory Infection Trajectory with Point of Care Testing During Clinical Consultation.

Quality of Life Changes in Respiratory Infection Trajectory with Point of Care Testing During Clinical Consultation.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: June 11, 2026

Tenders for generics and biosimilars: a challenging purchasing policy.

Tenders for generics and biosimilars: a challenging purchasing policy.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: March 08, 2023

Does diagnostic testing always decrease antibiotics prescriptions?

Does diagnostic testing always decrease antibiotics prescriptions?

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: December 02, 2021

Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations.

Diagnostic Testing for Sepsis: A Systematic Review of Economic Evaluations.

Journal: Antibiotics (Basel, Switzerland)

Published: November 11, 2021

Efficiency of Diagnostic Testing for Helicobacter pylori Infections-A Systematic Review.

Efficiency of Diagnostic Testing for Helicobacter pylori Infections-A Systematic Review.

Journal: Antibiotics (Basel, Switzerland)

Published: December 10, 2020

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model.

Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model.

Journal: Health economics review

Published: October 23, 2020

The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments.

The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments.

Journal: PharmacoEconomics

Published: September 20, 2019

Pre-approval incentives to promote adoption of personalized medicine: a theoretical approach.

Pre-approval incentives to promote adoption of personalized medicine: a theoretical approach.

Journal: Health economics review

Published: December 20, 2018

Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

Personalized Medicine and Pay for Performance: Should Pharmaceutical Firms be Fully Penalized when Treatment Fails?

Journal: PharmacoEconomics

Published: February 17, 2018

EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: December 01, 2017

Endogenous versus exogenous generic reference pricing for pharmaceuticals.

Endogenous versus exogenous generic reference pricing for pharmaceuticals.

Journal: International journal of health economics and management

Published: April 13, 2016

Improving health care systems by building 'more Europe'.

Improving health care systems by building 'more Europe'.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: March 24, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026